Answers are grounded in this paper and cite their sources.
INTRODUCTION . . . . . . . . . . . . .. . .... . . .... . . . . . . . . . . . . . . . . . . . . . .. . ... . . . .. . . . .. . . .. . . .. .. . .. . . . . . . . . . . 417 A Leishmania Primer 4 1 8 The Leishmania Genome and Circular DNAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 1 9 MULTIPLE MECHANISMS O F DRUG RESISTANCE. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 420 GEN ES AMPLIFIED IN RESPONS E TO DRUG PRESSURE . . . . . . . . . . . . . . . . . . . . ... . . .. . . 421 Dihydrofolate Reductase-Thymidylate Synthase. . . .. .. . . ....... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 421 The H Region: a Complex Multiple Drug-Resistance Element 422 Tunicamycin and Glycosyltransferase 425 ODC, IMPDH, and Classic MDR. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . 425 M ISCELLANEOUS AMPLIFIED GENES . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 426 T and D DNAs . . .. . . . .. . . . ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . .. .. . .. . .... .. . . . ... .. . . . . .. . . . . 426 Miniexon. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 427 Subchromosomal Amplifications . . . . . . . . . . . . . . . . . 427 What Leads to the Emergence of Apparently Nonfunctional Amplified DNAs? . .. . . . .. . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 428 FREQUENCY OF GENE AMPLIFICATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 429 STRUCTURE OF EXTRACHROMOSOMAL AMPLIFIED DNAs .... . . . . . . . . . . ... ... .... 429 Simple, Time-Invariant Direct and Inverted Amplifications . .. . . . . . . . . . . . . . .. . .. .. . . . . . . . 430 Unstable and Stable Amplification 430 Recurrence of Rearrangements Involving Repetitive DNA Sequences . . . . . . ... . . . . . . . . . 431 Functional Genetic Elements Within Amplified DNAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 1 Comparisons with Amplified DNAs in Cultured Mammalian Cells 432 Three Chromosomal Types of Amplification . .. . . . . . . .. . ... . . . . . . . .. . . . . . ... .. . . . ........ .. . . 432 M ECHANISM OF GENE AMPLIFICATION. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 433 ROLE OF GENE AMPLIFICATION IN LEISHMANIA BIOLOGY AND EVOLUTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 436 Clinical Drug Resistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 436 Amplified Genes in Leishmania: a Bridge Between Prokaryotic Resistance Factors and Mammalian Gene Amplifications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 437 Role of Amplification in Shaping the Parasite Genome . . . . . . . . . . . . . . . . ...... . . . .. . . . . . . . . 438 PROSPECTUS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... . . . . . . . 439
No takes yet. Share an insight, caveat, or question.
Stephen M. Beverley (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: